| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/03/2009 | EP2064209A1 Pyrrole derivatives with antibacterial activity |
| 06/03/2009 | EP2064181A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | EP1838715A4 Method for the preparation of maytansinoid esters |
| 06/03/2009 | EP1694684A4 Process for making camptothecin derivatives |
| 06/03/2009 | CN101448837A Novel epoxy compound and method for producing the same |
| 06/03/2009 | CN100494202C Spirofuropyridine aryl derivatives |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 06/02/2009 | US7541365 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 06/02/2009 | US7541364 Compounds of the above formula are useful as analgesics for treating pain; as immunomodulators, to modulate the behavioral effects of drugs of abuse and to modulate the development of tolerance and dependence of mu agonists. |
| 06/02/2009 | US7541346 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/02/2009 | US7541332 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 06/02/2009 | CA2474205C E2 displacement assay for identifying inhibitors of hpv |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/29/2009 | CA2644817A1 Quartz glass micro-photoreactor and synthesis of 10-hydroxycamptothecin and 7-alkyl 10-hydroxycamptothecin |
| 05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137586 Compounds for the treatment of inflammatory disorders |
| 05/28/2009 | US20090137554 1,4,5,6-TETRAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/27/2009 | EP2062901A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
| 05/27/2009 | EP2062898A2 Spirocyclic cyclohexane derivatives |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101443332A Anti-viral pyrimidine nucleoside derivatives |
| 05/27/2009 | CN101440097A 1-(3',4',5'- trisubstituted phenyl)- isoquinoline compound and medical use thereof |
| 05/27/2009 | CN101440096A 1-(3',4',5'- trisubstituted phenyl)- tetrahydroisoquinoline compound and its use |
| 05/27/2009 | CN101440095A 3-oxa acridone, derivatives thereof and preparation |
| 05/27/2009 | CN101440073A Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof |
| 05/26/2009 | US7538220 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 05/26/2009 | US7538219 Soft anticholinergic zwitterions |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | CA2533685C Nitrogen-containing fused heterocyclic carboxylic acid compounds |
| 05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064792A1 Quinolone carboxylic acid-substituted rifamycin derivatives |
| 05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 05/22/2009 | WO2009063780A1 Organic transistor |
| 05/22/2009 | WO2009062990A2 Equilibrative nucleoside transporter ent1 inhibitors |
| 05/22/2009 | WO2009062605A1 Trisubstituted furopyrimidines and the use thereof as activators of the ip receptor |
| 05/22/2009 | WO2009062289A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009037542A3 Spirocyclic compounds as stearoyl coa desaturase inhibitors |
| 05/22/2009 | WO2008136815A3 5, 6-ring annulated indole derivatives and use thereof |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705689A1 Trisubstituted furopyrimidines and the use thereof as activators of the ip receptor |
| 05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2704423A1 Equilibrative nucleoside transporter ent1 inhibitors |
| 05/21/2009 | US20090131682 Supports for oligomer synthesis |
| 05/21/2009 | US20090131672 3,4-cyclic phosphate prodrugs, including sodium-7-deoxynarcistatin, sodium-7-deoxy-transdihydronarcistatin, and sodium transdihydronarcistatin; anaticarcinogenic agent, antitumor agent; obtained via isolation from the medicinal plant species Narcissus (Amaryllidaceae), as precursors |
| 05/21/2009 | US20090131502 Biologically active compounds |
| 05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
| 05/21/2009 | US20090131498 Enantioselective Synthesis of Merrilactone and Its Analogs |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131412 Novel 2-quinolone derivative |
| 05/21/2009 | US20090130201 polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 05/21/2009 | US20090126932 Reversible polymeric gelation for oilfield applications |
| 05/20/2009 | EP2059519A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/20/2009 | EP1270549B1 Polymer-immobilized alpha-iminoester |
| 05/20/2009 | DE102007054786A1 Trisubstituierte Furopyrimidine und ihre Verwendung Trisubstituted Furopyrimidine and their use |
| 05/20/2009 | CN101437827A Process for producing optically active chromene oxide compound |
| 05/20/2009 | CN101437816A 2-aminopyridine analogs as glucokinase activators |
| 05/19/2009 | US7534799 Pyridomorphinans, thienomorphinans and use thereof |
| 05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534767 4-amino-7-(2-C-methyl- beta -D-ribofuranosyl)-furo[3,2-d]pyrimidine; 7-amino-3-(2-C-methyl- beta -D-ribofuranosyl)-1H-pyrazolo[4,3-d]pyrimidine; -amino-7-(2-C-methyl- beta -D-ribofuranosyl)-5H-pyrrolo[3,2-d]pyrimidine; hepatitis C virus (HCV) infection |
| 05/14/2009 | WO2009061597A1 Compounds for inhibiting ksp kinesin activity |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | WO2007067711A3 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 05/14/2009 | US20090124648 Such as trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide and novel salts, hydrates and polymorphs thereof; neuropeptide y5 (NPY5) |
| 05/14/2009 | CA2702995A1 Compounds for inhibiting ksp kinesin activity |
| 05/13/2009 | EP2058315A1 1H-Furo[3,2-C]Pyrazoles active as aurora kinase inhibitors |
| 05/13/2009 | EP2058303A1 Method for producing piperidin-4-one-derivative |
| 05/13/2009 | EP2057169A2 Compositions and methods of making a chlorin e6 derivative as a photoactive agent |
| 05/13/2009 | EP2057162A2 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | CN101432288A Process for production of camptothecin derivative |
| 05/13/2009 | CN101429232A Hcv protease inhibitors |
| 05/13/2009 | CN101429201A Lemon acid berbamine salt, preparation method and application thereof |
| 05/13/2009 | CN101429200A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 05/13/2009 | CN100486973C Novel benzodioxoles |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531550 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/07/2009 | WO2009059272A1 Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| 05/07/2009 | WO2009058728A1 Thiazole derivatives as protein kinase inhibitors |